Solution reagent kit HEMEaccuTest™

for hematologyNGSclinical

This is a precision diagnosis panel to detect major genetic variations related to malignant tumors in blood using NGS technology. NGS-based blood cancer genome analysis precision diagnosis HEMEaccuTest™ is an NGS-based diagnosis method designed to detect variants in more than 100 genes related to malignant tumors in blood, hemopoietic organs, lymph nodes, and lymph systems and to help patients select the optimal treatment method and therapy. Combination with genome big data automatic analysis software HEMEaccuTest™ may be used in combination with ‘NGeneAnalySys’ which is a genome big data auto analysis software program. NGS data produced from test reagents are applied to the bioinformatics pipeline, and all the steps from auto-analysis to reading and test sheet preparation are implemented in the one-stop process.